PAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Osaka International Cancer Institute today announced that they have formed an alliance to advance clinical development in Japan. The partnership …
( read original story …)


Related Post

Osaka woman arrested after 4 corpses of newborns f...
views 54
Osaka police arrested a 53-year-old woman after fo...
First Ascott The Residence property set to open in...
views 148
“Many of our customers have been eagerly anticipat...
Japan PM Abe pledges to protect people and propert...
views 148
Japan deployed its Patriot missile defence system ...
Probe into safety of Fukushima nuclear power plant...
views 96
A magnitude 6.3 quake has hit Japan’s Kanto ...
Bank of Japan March meeting summary: Policy will r...
views 133
TOKYO (Reuters) - Bank of Japan board members said...
North Korea: Earthquake near nuclear site sparks f...
views 86
The test launch of a Hwasong-12 intermediate range...
Japan’s retail stock traders begin tapping p...
views 55
TOKYO -- Japan's brokerages are bringing the power...
Review: American Airlines Business Class 777-200 L...
views 101
In the interest of full disclosure, Monkey Miles e...
Central bank's rate focus hides urge to taper
views 96
TOKYO -- The Bank of Japan's interest rate-based m...
North Korea fires second ballistic missile over Ja...
views 96
North Korea has fired a ballistic missile across J...